Tulane UniversityKenner, Louisiana, United States
Academic Hospitalist
0267: Pharmacosurvellience study of FDA Adverse Event Reporting System (FAERS) events of Secukinumab and Guselkumab
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose